Posts by John

Treating clinical trials as high-stakes bets threatens medical integrity. Learn why prioritizing scientific rigor over speculation is vital for patient care.

Aurobindo Pharma’s API manufacturing site successfully passes a recent USFDA inspection, ensuring compliance and supply chain stability for generic drugs.

New study shows intravaginal magnesium sulfate could speed up labor more effectively than traditional methods. Learn the impact on obstetric care.

Genencell stock faced a sharp sell-off after clinical trial approval. Explore the risks of biotech speculation and the importance of long-term data.

Vezeeta and Eva Pharma launch a new digital care pathway in Egypt, providing subsidized treatment and integrated support for obesity and diabetes patients.

Sun Pharma secures CDSCO approval for a Phase IV trial of Sovateltide. Explore the clinical impact of this neuro-regenerative drug development.

Phase III MAVERICK trial findings suggest brain MRI surveillance is an effective alternative to prophylactic radiation in small-cell lung cancer patients.

New trial data reveals mitapivat significantly reduces transfusion needs in thalassemia patients, signaling a potential shift in standard medical care.

Learn why proximity to CMOs is becoming the primary factor in site selection for Parkinson's imaging trials to ensure radiopharmaceutical stability.

Johnson & Johnson has sold its Laminar program to Jaguar LAA, exiting the stroke-prevention market for AFib patients. Learn about the strategic shift.